Boqii Holding Limited

Macroaxis’ model-based outlook assigns Boqii a “Strong Sell” rating over a 90‑day horizon, highlighting negative margins, elevated leverage, and very high odds of financial distress even though the stock screens below its model-estimated valuation. The report frames BQ as a volatile penny stock where fundamental and price signals both skew negative, and positions its output as comparative research support rather than individualized advice for average‑risk investors.

CirclFi’s Deep Alpha Valuation Engine runs five models on BQ and finds that four indicate upside from roughly \$0.85 to a composite fair value of \$1.53, with a bull‑case topology target of \$2.76 suggesting substantial return potential. While the report flags an elevated value‑trap score, wide dispersion between bullish and bearish models, and sector risks, it ultimately characterizes BQ as a “high‑conviction opportunity” for investors who can tolerate analytical uncertainty and volatility.

TradingKey’s June 2026 report scores BQ’s fundamentals and valuation as relatively sound with high growth potential and strong institutional interest, but notes that the stock ranks poorly on momentum and risk within the specialty retail industry. It expects a medium‑term downtrend and emphasizes very high price volatility and beta, suggesting BQ is better suited to range‑bound swing trading than to long‑term buy‑and‑hold investors.

KoalaGains’ research report, updated April 23, 2026, describes a catastrophic financial decline at BQ, including about a 33.9% collapse in revenue to roughly CNY 468.9 million and deeply negative free cash flow that has forced repeated share issuance and investor dilution. Benchmarking BQ against larger peers, the analysis argues the company lacks scale, pricing power, and a defensible moat, concludes that its business model is structurally broken, and explicitly recommends avoiding the stock entirely given delisting risk and severe unprofitability.

Simply Wall St’s infographic-style analysis (company analysis timestamped December 11, 2025) assigns BQ low scores for valuation, future growth, and past performance but a strong score for financial health, and details weak profitability metrics alongside modest revenue. The report highlights extreme share-price volatility, regulatory and delisting concerns, and a lack of clear long-term performance track record while noting coverage by several sell‑side analysts, but stops short of an explicit buy or sell recommendation.